Silymarin for HCV infection

59Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Silymarin, an extract of milk thistle seeds, and silymarinderived compounds have been considered hepatoprotective since the plant was irst described in ancient times. Hepatoprotection is deined as several non-mutually exclusive biological activities including antiviral, antioxidant, anti-inlammatory and immunomodulatory functions. Despite clear evidence for silymarin-induced hepatoprotection in cell culture and animal models, evidence for beneicial effects in humans has been equivocal. This review will summarize the current state of knowledge on silymarin in the context of HCV infection. The information was collated from a recent workshop on silibinin in Germany. © 2013 International Medical Press.

Cite

CITATION STYLE

APA

Polyak, S. J., Oberlies, N. H., Pécheur, E. I., Dahari, H., Ferenci, P., & Pawlotsky, J. M. (2013). Silymarin for HCV infection. Antiviral Therapy. https://doi.org/10.3851/IMP2402

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free